In 2024, the U.S. Drug Enforcement Administration (DEA) indicated they plan to reclassify marijuana like a Schedule III drug. This rescheduling will recognize that cannabis has legitimate healthcare applications and should help open the door to exploration on other possible remedy makes use of.